echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > "Pharmaceutical speed reading society" supplies national mining open multinational pharmaceutical giants again trapped "kickback door"

    "Pharmaceutical speed reading society" supplies national mining open multinational pharmaceutical giants again trapped "kickback door"

    • Last Update: 2020-07-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    July 5, 2020 / Medical Information List: The latest notice of the 2019 national investigation and sale of counterfeit and inferior drugs has arrived; 2 pharmaceutical companies have cancelled the Drug Production License; Redseyway has been granted conditional approval by the European Union; and Johnson and Johnson's heavy anti-cancer drugs have submitted two new listing applications in China..Daily fresh medicine to hear medical news, fast-reading society with you to pay attention!Recently, the State Medical Insurance Administration issued a letter on the commission of the "National Organization Coronary Bracket Concentrated Band Procurement Program (Draft for Comments)" for commentsThis bodes well for the start of the national collection of high-value consumables(State Medical Insurance Bureau)recently, the State Drug Administration on the 2019 national drug regulatory departments at all levels of the investigation and sale of counterfeit and inferior drugs, the notice showed that in 2019 a total of 22,342 drug production enterprises, 35,746 pharmaceutical wholesale enterprises, pharmaceutical retail enterprises 937648 times, ordered the suspension of 1394 households(State Drug Administration)3, Jiangsu Province Public Resources Trading Center issued the "notice on the publication of the suspension of the suspension of the results of drug classification" shows that as many as 5,336 drugs were suspended or even revoked(Jiangsu Province Public Resources Trading Center)3, Sichuan Health and Health Commission issued "on the launch of the 2020 year 2020 second and third-level public hospital performance appraisal related work notice", "Notice" requires that the relevant hospitals in accordance with the specific requirements of the national public hospital performance appraisal operation manual, on time to log on to the public hospital performance appraisal management platform, online fill in relevant data and supporting data, and by the hospital legal person after review and confirmation(Sichuan Health and Welfare Commission), Novartis recently paid the U.SDepartment of Justice $729 million in settlements for providing illegal kickbacks to doctors and patients in the United States(E drug manager)recently, 2 pharmaceutical companies to cancel the drug production licenseThey are Liaoning Jindan Pharmaceutical Co., Ltdand Hunan Yanchun Pharmaceutical Co., LtdAmong them, Liaoning Jindan Pharmaceuticals was twice withdrawn the drug GMP certificate(Dandelion)today, Gilead announced today that the European Commission has granted Veklury (remdesivir) conditional on the market for the treatment of adult and adolescent patients with new coronary pneumonia who need oxygen supplements caused by the new coronavirus infection(Pharmaceutical Mingkang)the latest notice of CDE, Johnson and Johnson's Yangsen Pharmaceutical CD38 monoclonal antibody DaretoYu monoimmune injection, in China submitted two new indications listing applicationsAcacia Pharma has approved the listing of its Byfavo (remimazolam) with the Fda to induce and maintain the sedation of adult patients who undergo medical procedures (duration spending less than 30 minutes) during medical procedures, acacia Pharma announcedThe European Commission has approved a summary of Idelvion's new product features, which include information on new and expanded dose selection, thejetbellin announced recently(Biological Valley)4, North China Pharmaceuticals submitted a class 1 new drug recombinant human-derived anti-rabies virus single anti-injection application was accepted by CDE(Pharma Rubik's Cube)a few days ago, Hengrui Pharmaceuticals submitted a class 1 new drug Haiquupa ethanolamine tablets 2nd indication application was accepted by CDE(Pharma Rubik's Cube) on the 4th, Shi Pharma Group subsidiary Shanghai Enlemei Biotech Co., Ltdsubmitted a clinical application for a new class of drug ALMB-0168 injection was accepted by CDE(Pharma Rubik's Cube)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.